What we found on the web about Detemir
Insulin detemir is a long-acting human insulin analogue for maintaining the basal level of insulin. Novo Nordisk markets it under the trade name Levemir.
Novo Nordisk created insulin detemir and markets it under the trade name Levemir as a long-lasting insulin analogue for maintaining the basal level of insulin.
Insulin detemir is a man-made form of a hormone that is produced in the body. It works by lowering levels of glucose (sugar) in the blood. Insulin detemir is a long-acting form ...
A new, long-acting insulin analog (modified, synthetic form of insulin) that acts in the bloodstream for up to 24 hours. Marketed under the brand name Levemir, detemir is approved ...
Find patient medical information for Insulin Detemir SubQ on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
PharmaCETM is a service offering accredited online continuing education (CE) programs to pharmacy professionals published from The Annals of Pharmacotherapy and the journal of ...
Insulin Detemir (Levemir R) Why do we need basal insulin? What is Detemir? How is it used? How does it differ from Human Insulin? How long does it’s effect last after injection?
A randomised, parallel group open label trial to explore the hypothesis that use of insulin detemir vs. insulin glargine will lead to reduced weight gain in young women with T1D.
Insulin determir is only part of a complete program of treatment that may also include diet, exercise, weight control, foot care, eye care, dental care, overall proper health care ...
Here is what users have to say about Detemir

Insulin detemir is a long-acting human insulin analogue for maintaining the basal level of insulin. Novo Nordisk markets it under the trade name Levemir. It is an insulin analogue in which a fatty acid (myristic acid) is bound to the lysine amino acid at position B29 . It is quickly resorbed after which it binds to albumin in the blood through the fat acid at position B29. It then slowly dissociates from this complex.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Detemir
StreetInsider.com
Superior Efficacy-dose Ratio for Lantus(R) Over detemir More than 140 Companies Already Registered for the 2010 IR Global Rankings ... August 30, 2009 6:12 AM EDT PARIS, August 30 /PRNewswire-FirstCall/ --- SEPIA-ACS Multiple-dose Phase II ...
Corpus Christi Caller
Unfortunately, the study didn’t look at insulin detemir (Levemir), the other long-acting insulin analog. However, studies reported at the same time showed no clear confirmation of a risk of cancer with glargine use. While these data are ver...
News-Medical.Net
Sanofi-aventis announces study results comparing efficacy of Lantus to detemir Sanofi-aventis announced today results of a head-to-head study providing further evidence on the eff... HPN-100 drug receives orphan product designation Hyperion...
PharmiWeb
About Levemir® (insulin detemir [rDNA origin] injection) Levemir (insulin detemir [rDNA origin] injection) is a long-acting modern insulin (insulin analogue) indicated for once- or twice-daily subcutaneous administration for the treatment o...
News-Medical.Net
Sanofi-aventis announces study results comparing efficacy of Lantus to detemir Sanofi-aventis announced today results of a head-to-head study providing further evidence on the eff... Dapagliflozin trial results indicate improvement in key g...
Science Daily
However, study participants who used insulin detemir discontinued the study more often due to adverse events than those using insulin glargine. On average, patients in the detemir group put on less weight than those in the glargine group. H...
Medscape News
Vague P, Selam JL, Skeie S et al. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with Type 1 diabetes on a basal-bolus regimen with premeal insulin aspart. ...
PR Newswire
PRINCETON, N.J., May 8 /PRNewswire/ -- Novo Nordisk today announced results from the TITRATE(R) study showing that Levemir(R) (insulin detemir [rDNA origin] injection), taken once-daily, substantially lowered average blood sugar. Type 2 dia...
Earthtimes
About Levemir (R) (insulin detemir [rDNA origin] injection) Levemir(R) is indicated for once- or twice-daily subcutaneous administration for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with ...
MSN Money
- 76% Higher Dose of Insulin detemir Needed to Achieve Similar, Well Tolerated Glycemic Control Versus Lantus(R) Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today results of a head-to-head study providing further evidence on the ...
Science Daily
Newer drugs, insulin analogues such as insulin glargine (trade name Lantus) and insulin detemir (Levemir), have been marketed as an improvement over NPH. However, the reviewers found that Lantus and Levemir were almost identical to NPH in l...